“One year of doing advocacy on antimicrobial resistance” by Aanika Dalal, DavidMcK

It's been just over a year since ARMoR launched through the CE/AIM incubation program! In that time, we’ve worked hard to push for policies that will help tackle the rising threat of antimicrobial resistance (AMR) and made some strong progress towards this aim. As part of our anniversary, we want to take the opportunity to: Explain why AMR is so important Share a little about how our first year has gone Make the case for why our work is worth supporting Please contact us at [email protected] if you have any questions, comments, feedback, or are interested in donating! TL;DR  Antimicrobial resistance is a serious global health threat.  We need a continuous pipeline of new antimicrobials coming to market to replace those which are no longer effective.  Market incentives have failed to stimulate the needed innovation.  Significant analysis has suggested that ‘pull incentives’ could be a highly [...] ---Outline:(00:49) TL;DR(02:05) Antimicrobial resistance is a looming global health crisis(02:11) The growing health burden of antimicrobial resistance(04:01) The market failure preventing antibiotic development(06:24) Fixing the market failure with pull incentives(08:33) Global Access and Stewardship Conditionalities(09:12) Our first year: research, advocacy, and informational lobbying(13:57) Programs, Progress, and Next Steps(22:41) Cost-effectiveness of AMR advocacy(24:39) The impact of Marginal Funds(26:06) ConclusionThe original text contained 3 footnotes which were omitted from this narration. The original text contained 1 image which was described by AI. --- First published: November 11th, 2024 Source: https://forum.effectivealtruism.org/posts/HXqzmahbjJwwiX9Si/one-year-of-doing-advocacy-on-antimicrobial-resistance --- Narrated by TYPE III AUDIO. ---Images from the article:Apple Podcasts and Spotify do not show images in the episode description. Try Pocket Casts, or another podcast app.